Saturday, November 13, 2021 8:01:28 PM
This is quite an interesting theory, or might I say, opinion based on knowledge and research, coming from a man in his position!
“Stefan Oelrich, president of Bayer’s Pharmaceuticals Division, made these comments at this year’s World Health Summit, which took place in Berlin from October 24-26 and hosted 6,000 people from 120 countries. Oelrich told his fellow international “experts” from academia, politics, and the private sector that the novel mRNA COVID “vaccines” are actually “cell and gene therapy” that would have otherwise been rejected by the public if not for a “pandemic” and favorable marketing.” We are really taking that leap [to drive innovation] – us as a company, Bayer – in cell and gene therapies … ultimately the mRNA vaccines are an example for that cell and gene therapy. I always like to say: if we had surveyed two years ago in the public – ‘would you be willing to take a gene or cell therapy and inject it into your body?’ – we probably would have had a 95% refusal rate,” stated Oelrich.
“Our successes over these 18 months [the duration of the COVID ‘pandemic’] should embolden us to fully focus much more closely on access, innovation, and collaboration to unleash health for all, especially as we enter, on top of everything else that is happening, a new era of science – a lot of people talk about the Bio Revolution in this context,” continued the businessman.
According to the McKinsey Global Institute, the “Bio Revolution” is “a confluence of advances in biological science and accelerating the development of computing, automation, and artificial intelligence [that] is fueling a new wave of innovation. This Bio Revolution could have a significant impact on economies and our lives, from health and agriculture to consumer goods, and energy and materials.”
In addition to gene therapy and a biological “revolution,” Oelrich also mentioned the role his company has, along with other prominent institutions and figures, in pushing contraception in developing countries.
“We also need to focus on what is socially responsible outside of Europe and ensure sustainable action there. We pledged, this past year, to give an additional hundred million women access to contraception in the world. We’ve invested 400 million this year into new plants that are dedicated to producing long-acting contraceptives for women in low-and-middle-income countries … Together with Bill and Melinda Gates we’re working very closely on family planning initiatives,” said Oelrich, implying one of the methods of attaining a “sustainable” world is by reducing births, and subsequently reducing the planet’s population.
I truly recommend watching the entire video listed above for better insights and tips, and advice to get the entire image about what’s truly going on with the vaccines and the global vaccination agenda, that’s now being pushed in the next phase, and burdened upon children!https://thetruedefender.com/bayer-executive-mrna-shots-are-gene-therapy-marketed-as-vaccines/
ANYTHING CAN HAPPEN TO YOUR INVESTMENTS PLEASE DO YOUR DD BEFORE INVESTING AND MAKE $$$$$$$
Recent PFE News
- Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union • Business Wire • 09/20/2024 12:11:00 PM
- Targeting Cancer's Achilles Heel: AI-Driven DDR Therapies Offer Hope • AllPennyStocks.com • 09/17/2024 09:01:00 PM
- Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call with Analysts • Business Wire • 09/17/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 05:12:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 05:11:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 05:06:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 05:04:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 04:57:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 04:56:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 04:54:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 04:53:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 04:52:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 04:47:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 04:45:23 PM
- Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab in Patients with Cancer Cachexia • Business Wire • 09/14/2024 12:45:00 PM
- Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer • Business Wire • 09/14/2024 08:15:00 AM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 09/13/2024 08:49:43 PM
- Pfizer Highlights Diverse Oncology Portfolio and Combination Approaches at ESMO 2024 • Business Wire • 09/11/2024 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 10:10:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 10:05:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 10:05:28 PM
- Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference • Business Wire • 08/28/2024 02:00:00 PM
- Pfizer Launches PfizerForAll™, a Digital Platform that Helps Simplify Access to Healthcare • Business Wire • 08/27/2024 10:45:00 AM
- Cruise and Uber Join Forces for Robotaxis, Alibaba Shifts Primary Listing to Hong Kong, Altria Hikes Dividend 4.1% • IH Market News • 08/23/2024 12:20:26 PM
- Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine • Business Wire • 08/22/2024 06:15:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM